Skip to main content
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. — Investor Relations & Filings

Ticker · IDYA ISIN · US45166A1025 LEI · 549300ULW08F62IJML11 US Manufacturing
Open in API
Filings indexed 466 across all filing types
Latest filing 2021-04-16 Regulatory Filings
Country US United States of America
Listing US IDYA

About IDEAYA Biosciences, Inc.

https://www.ideayabio.com/

IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3. It is a correspondence related to a securities registration process, specifically about the timing of the effectiveness of a registration statement. The document does not contain financial statements, audit information, or detailed report content. It is a regulatory communication related to capital raising but is not itself a capital/financing update report or a registration statement filing. Given the short length (1518 characters) and the nature of the content (a formal request letter), this fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and correspondence that do not fit other categories.
2021-04-16 English
Regulatory Filings 2021
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify the document as any specific filing type. According to the fallback rule, when a document does not fit any specific category, it should be classified as a Regulatory Filing (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable. Therefore, the best classification is RNS with moderate confidence due to lack of content clarity.
2021-03-25 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered to employees under stock plans such as incentive award plans and employee stock purchase plans. It includes details about the securities to be registered, references prior registration statements, and incorporates by reference the company's Annual Report on Form 10-K and other filings. The document is not an annual report itself, nor is it an earnings release or other financial report. It is a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, it fits best under the category of Regulatory Filings (RNS).
2021-03-23 English
S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a registration statement under the Securities Act of 1933 used for registering securities offerings. The document includes details about the securities to be offered, the registration fee, and legal disclaimers. It is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement or notice, so it is not an RPA or RNS. Hence, the classification is CAP with high confidence.
2021-03-23 English
10-K
Annual Report FY 2020
2021-03-23 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 23, 2021, reporting the company's financial results for the fourth quarter ended December 31, 2020. It includes a press release as Exhibit 99.1 announcing these results. The text explicitly states that the press release is furnished and not filed, and the document itself is a current report (8-K) rather than a full earnings release or quarterly report. The document length is 3592 characters, which is relatively short and mainly serves as an announcement of the earnings results rather than containing detailed financial statements or analysis. According to the classification rules, initial announcements of quarterly or periodical financial results (key highlights only) correspond to Earnings Release (ER). Since this is a press release announcing quarterly financial results, the correct classification is ER with high confidence.
2021-03-23 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.